Maria Jesus Gonzalez-Rellan
Maria Jesus Gonzalez-Rellan is a postdoctoral researcher in Dr. Daniel Drucker’s lab at Mount Sinai Hospital, originally from Spain. She is investigating the mechanisms by which semaglutide improves liver function in patients with metabolic dysfunction-associated steatohepatitis (MASH), revealing important insights into weight-loss independent benefits of GLP-1 receptor agonists.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Canada | 1 | 8.00 | 0.09% | +0% | 38,005,238 | 33,964 | $1,700,000 | 1,519$ |
| Totals | 1 | 38,005,238 | 33,964 | $1,700,000 | 1,519$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Dr. Maria Jesus Gonzalez-Rellan has been experimenting on mice to figure out why semaglutide improves liver function in people with severe fatty liver disease.
8